View in EDS HTML Full Text PDF Full Text

First‐in‐human development of a pharmacodynamic biomarker for PAC1 receptor antagonists using intradermal injections of maxadilan.

Saved in:
Bibliographic Details
Title: First‐in‐human development of a pharmacodynamic biomarker for PAC1 receptor antagonists using intradermal injections of maxadilan.
Authors: Marynissen, Heleen1 (AUTHOR) heleen.marynissen@uzleuven.be, Buntinx, Linde2 (AUTHOR), Bamps, Dorien1 (AUTHOR), Depre, Marleen1 (AUTHOR), Ampe, Els1 (AUTHOR), Van Hecken, Anne1 (AUTHOR), Gabriel, Kristin3 (AUTHOR), Sands, Steve4 (AUTHOR), Vargas, Gabriel5 (AUTHOR), de Hoon, Jan1 (AUTHOR)
Source: CTS: Clinical & Translational Science. Aug2022, Vol. 15 Issue 8, p1968-1977. 10p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:17528054
DOI:10.1111/cts.13309